A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy
Titel:
A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy
Auteur:
Berdel, Andrew F. Koch, Raphael Gerss, Joachim Hentrich, Marcus Peceny, Rudolf Bartscht, Tobias Steffen, Björn Bischoff, Marina Spiekermann, Karsten Angenendt, Linus Mikesch, Jan-Henrik Kewitz, Tobias Butterfass-Bahloul, Trude Serve, Hubert Lenz, Georg Berdel, Wolfgang E. Krug, Utz Schliemann, Christoph